Fiche publication
Date publication
janvier 2026
Journal
Pain research & management
Auteurs
Membres identifiés du Cancéropôle Est :
Dr KREMER Mélanie
,
Dr YALCIN CHRISTMANN Ipek
Tous les auteurs :
Belaise T, Kremer M, Poulain B, Yalcin I, Bohren Y
Lien Pubmed
Résumé
Neuropathic pain occurs as a direct consequence of a lesion or a disease affecting the somatosensory system. Because of the limited therapeutic arsenal, it is difficult to treat. Nevertheless, pain relief has been demonstrated in multiple clinical trials treating neuropathic pain patients with subcutaneous or intradermal administrations of botulinum toxin. However, this type of administration route shows limits; for example, the painful area may be too large for subcutaneous administration, or administration discomfort would be intolerable for direct injection into the painful area. For these reasons, alternative routes have been investigated, including the perineural one.
Mots clés
Botulinum toxin, neuropathic pain, perineural injection
Référence
Pain Res Manag. 2026 ;2026(1):e6539538
